Market Indices
Latest News
 |
Clearside Biomedical, Inc. (CLSD) confirmed earnings release on March 20, 2026,...
March 19, 2026 |
| ||
| ||
| ||
|
Price Targets
Roger Song from Jefferies issued a price target of $16.00 for CTMX on 2026-03-18 14:16:00.The adjusted price target was set to $16.00.At the time of the announcement, CTMX...
March 18, 2026 CTMX 8.14%
Stephen Willey from Stifel Nicolaus issued a price target of $17.00 for ABEO on 2026-03-17 19:53:00.The adjusted price target was set to $17.00.At the time of the announcement,
March 17, 2026 ABEO -0.09%
Michael Baker from D.A. Davidson issued a price target of $68.00 for CTRN on 2026-03-17 19:35:00.The adjusted price target was set to $68.00.At the time of the announcement,
March 17, 2026 CTRN 0.55%
Greg Renza from Truist Financial issued a price target of $12.00 for CATX on 2026-03-17 12:35:00.The adjusted price target was set to $12.00.At the time of the announcement,
March 17, 2026 CATX -6.07%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| DLTH Duluth Holdings Inc. | 3.22
48.39% | ||||||||||||||||||
| SLNG Stabilis Solutions, Inc. | 3.97
21.25% | ||||||||||||||||||
| ALDX Aldeyra Therapeutics, Inc | 1.72
20.77% | ||||||||||||||||||
| CDIOW Cardio Diagnostics Holdin | 0.02
15.43% | ||||||||||||||||||
| ORGNW Origin Materials Inc Warr | 0.00
15.15% | ||||||||||||||||||
| AXTI AXT, Inc. | 56.05
14.94% | ||||||||||||||||||
| SPIR Spire Global, Inc. | 12.33
14.80% | ||||||||||||||||||
| NNBR NN, Inc. | 1.38
12.10% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -0.46%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 0.66%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 3.64%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 0.03%